Quantcast
Last updated on April 17, 2014 at 13:47 EDT

ChemAxon’s New US East Coast Headquarters Open in Cambridge, MA

September 25, 2012

BUDAPEST, Hungary and CAMBRIDGE, Massachusetts, September 25, 2012 /PRNewswire/ –

ChemAxon
[http://www.chemaxon.com/?utm_source=Press+Release+Test&utm_campaign=a01c993ff6-PR_ChemAxon_US_East_Coast_Headquarters&utm_medium=email ]
, a leader in providing chemistry software
solutions and consulting services for life science research, announces the opening of its
new US East Coast headquarters in Cambridge, MA. Located at the heart of Boston’s
biotechnology hub, these new offices will concentrate technical, scientific and
consultancy support as well as business development operations. ChemAxon is also
recruiting to meet strong growth in demand for its chemistry software in this region.

ChemAxon sets the standard in chemically-intelligent software for new product R&D.
With a client list that includes all of the top 15 global pharmas, the company continues
to experience significant growth year on year.

“Going forward our strategy is about developing the strong collaborative relationships
we have with customers and business partners,” commented Alex Drijver, CEO of ChemAxon.
“Locating in this key US pharma-biotech hub helps us ensure our technology evolves with
customer requirements, and they gain more business value from their chemistry.”

ChemAxon’s new US East Coast regional headquarters are at ChemAxon Services LLC,
Cambridge Innovation Center, One Broadway, Cambridge, MA 02142, USA. To discover more
about how ChemAxon’s leading edge cross platform solutions power modern cheminformatics
and chemical communication, please visit http://www.chemaxon.com

About ChemAxon

ChemAxon
[http://www.chemaxon.com/?utm_source=Press+Release+Test&utm_campaign=a01c993ff6-PR_ChemAxon_US_East_Coast_Headquarters&utm_medium=email ]
is a leader in providing cheminformatics
software platforms and desktop applications for the biotechnology, pharmaceutical and
agrochemical industries. With core capabilities for structure visualization, search and
management, property prediction, virtual synthesis, screening and drug design, ChemAxon
focuses upon active interaction with users and software portability to create powerful,
cost effective cross platform solutions that power modern cheminformatics and chemical
communication. The company is privately owned with European headquarters in Budapest, US
East Coast headquarters in Cambridge, MA, and sales and support offices in Europe, Japan
and across North America.

A concise corporate profile for ChemAxon can be found at

http://www.chemaxon.com/about-us/overview

SOURCE ChemAxon


Source: PR Newswire